Overview

Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma

Status:
Recruiting

Trial end date:
2024-09-15

Target enrollment:

Participant gender:

Summary

The goal of this clinical trial is to explore the effectiveness and adverse reactions of doxepin solution spray for alleviation of stubborn breakthrough pain induced by swallowing in patients receiving radiotherapy for nasopharyngeal carcinoma.

Phase:

N/A

Details

Lead Sponsor:

Nanfang Hospital, Southern Medical University

Treatments:

Doxepin